Pluri Inc - PLUR Choraklik daromad o'sishi

Pluri (PLUR) - korporativ logo

Pluri Inc. (PLUR) kompaniyasidagi joriy yo'qotishlar va strategik yo'nalishning o'zgarishi allaqachon narxga kiritilgan. Choraklik savdoning foizdagi o'sishi biznesning fundamental barqarorligini baholash imkonini beradi, bunda 140.80 belgisi tegishli ko'rsatkich vazifasini o'taydi. Kelajakdagi istiqbollar PLX 3D platformasining tasdiqlanishi va klinik ma'lumotlarga bog'liq. Bozor kapitalizatsiyasi biofarmatsevtika va kultivatsiya qilingan go'shtga tayanadi hamda innovatsion sog'liqni saqlash mahsulotlaridan olinadigan royalti orqali daromadlarni va'da qiladi.

PLUR Pluri Inc. Choraklik sotuv ortish sur'ati (28.04.2023 - 20.11.2026)

Pluri Inc. (PLUR) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy kotirovkalar va o'rtacha qiymat prognozi:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning fundamental baholanishi:Pluri - PLUR
Pluri Inc seriyali mahsuloti

Pluri Inc. kompaniyasining tijorat daromadlari dinamikasi nol chiqindili biotexnologiyalarning joriy etilishi va dori sintezi jarayonida suv iste'molini optimallashtirish orqali mustahkamlangan biznes modelining barqarorligini tasdiqlaydi. Choraklik daromadlar o'sish sur'atini tahlil qilish orqali investor uch oy davomidagi daromadning foiz o'zgarishini kuzatishi mumkin, bu esa o'tgan muvaffaqiyatlarga ko'r-ko'rona tayanmasdan, Sharpe va Sortino koeffitsientlari yordamida aktivning risk profili va tebranishlarini matematik jihatdan aniqlashtirish imkonini beradi.

Pluri Inc. (PLUR) raqobatchilari

ASND - Daromadning choraklik o'sishi (QoQ)|MDGL: Daromadning choraklik o'sishi (QoQ)|CORT: Choraklik daromad o'sishi|RYTM - Choraklik sotuv ortish sur'ati|Daromadning choraklik o'sishi (QoQ) Akero Corp|Metsera Therapeutics (MTSR) - Choraklik sotuv ortish sur'ati|Daromadning choraklik o'sishi (QoQ) moonlaketx.com (MLTX)|Choraklik sotuv o'sishi Crinetics Pharmaceuticals CRNX|Daromadning choraklik o'sishi (QoQ) NewAmsterdam Pharma N.V. NAMS|Choraklik sotuv ortish sur'ati Soleno Therapeutics Inc (SLNO)|FOLD - Daromadning choraklik o'sishi (QoQ)|ETNB: Daromadning choraklik o'sishi (QoQ)|AGIO: Choraklik daromad o'sishi|Structure Therapeutics Inc. - Choraklik daromad ortishi|MDXG (MiMedx Corp) - Choraklik daromad o'sishi|Choraklik daromad o'sish sur'ati Rezolute Inc RZLT|Choraklik daromad o'sishi LXRX|Choraklik sotuv ortish sur'ati MBX Corp|Altimmune Pharma - Choraklik sotuv o'sishi|Choraklik daromad o'sishi aardvarktherapeutics.com AARD|SGMT: Choraklik sotuv o'sishi|Choraklik daromad ortishi BIOA (BioAge Labs)|BMEA: Choraklik daromad o'sishi|QNCX: Sotuvning choraklik o'zgarishi|GUTS (Fractyl Health, Inc.) - Choraklik daromad o'sishi|Choraklik daromad o'sishi vtvtherapeutics.com|Choraklik sotuv o'sishi ATPC (Agape ATP Corp)|Choraklik sotuv ortish sur'ati Synlogic Inc.|Daromadning choraklik o'sishi (QoQ) Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Choraklik daromad o'sish sur'ati|Spruce Biosciences Inc. - Choraklik daromad o'sishi|Choraklik sotuv ortish sur'ati Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Daromadning choraklik o'sishi (QoQ)|Lumos Pharma - Choraklik daromad ortishi|ONVO (Organovo Corp) - Choraklik daromad o'sishi|Radius Pharmaceuticals (RDUS) - Choraklik sotuv ortish sur'ati